ID Source | ID |
---|---|
PubMed CID | 2733928 |
CHEMBL ID | 1321219 |
MeSH ID | M0444058 |
Synonym |
---|
AC-004 |
acetylcarnitine l-form hydrochloride |
acetylcarnitine l-form hcl |
ndw10mx58t , |
acetylcarnitine chloride |
1-propanaminium, 2-(acetyloxy)-3-carboxy-n,n,n-trimethyl-, chloride, (r)- |
unii-ndw10mx58t |
nsc 747431 |
acetyl l-carnitine hydrochloride |
MLS001332367 |
smr000875234 |
MLS001332368 |
o-acetyl-l-carnitine hydrochloride, >=99% (titration), powder |
r-(-)-2-acetyloxy-3-carboxy-n,n,n-trimethyl-1-propanaminium chloride |
BMSE000464 |
(r)-3-acetoxy-4-(trimethylammonio)butyrate hydrochloride |
AKOS005138019 |
acetylcarnitine hydrochloride |
1-propanaminium,n,n-trimethyl-, chloride, (2r)- |
nsc747431 |
(3-carboxy-2-hydroxypropyl)trimethylammonium acetate (ester) chloride |
normobren |
oristar ach |
branigen |
acetyl carnitine hcl |
acetylcarnitine hydrochloride, l- |
nsc-747431 |
HMS2233G09 |
AKOS015963427 |
acetyl-l-carnitine chloride |
o-acetyl-l-carnitine hcl |
acetylcarnitine hydrochloride [mart.] |
acetylcarnitine hydrochloride [who-dd] |
acetylcarnitine hydrochloride [mi] |
1-propanaminium, 2-(acetyloxy)-3-carboxy-n,n,n-trimethyl-, chloride (1:1), (2r)- |
acetyl carnitine hcl [inci] |
ammonium, (3-carboxy-2-hydroxypropyl)trimethyl-, chloride, acetate, (-)- |
[(2r)-2-acetoxy-3-carboxy-propyl]-trimethyl-ammonium |
CHEMBL1321219 |
[(2r)-2-(acetyloxy)-3-carboxypropyl]trimethylazanium chloride |
acetyl-l-car-nitine hydrochloride |
(r)-2-acetoxy-3-carboxy-n,n,n-trimethylpropan-1-aminium chloride |
acetyl-l-carnitine hydrochloride, >/=99% |
AS-11664 |
CCG-266869 |
Q27295965 |
1-propanaminium, 2-(acetyloxy)-3-carboxy-n,n,n-trimethyl-, chloride, (2r)- (1:1) |
Product Category | Products |
---|---|
Active Lifestyle & Fitness | 1 |
Product | Brand | Category | Compounds Matched from Ingredients | Date Retrieved |
---|---|---|---|---|
MRM Driven Pre-Workout Boost Mixed Berries -- 12.3 oz | MRM | Active Lifestyle & Fitness | citric acid, Vitamin C, Betaine Anhydrous, Acetyl L-Carnitine Hydrochloride, citric acid, N-Acetyl Tyrosine, N-Acetyl Tyrosine, Niacin, Pantothenic Acid, Vitamin B6, Taurine, Trehalose, Vitamin B12, Vitamin B6 | 2024-11-29 10:47:42 |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 5.6234 | 0.0447 | 17.8581 | 100.0000 | AID485294 |
TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 0.6310 | 1.7783 | 16.2081 | 35.4813 | AID652104 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
RNA polymerase II cis-regulatory region sequence-specific DNA binding | TAR DNA-binding protein 43 | Homo sapiens (human) |
DNA binding | TAR DNA-binding protein 43 | Homo sapiens (human) |
double-stranded DNA binding | TAR DNA-binding protein 43 | Homo sapiens (human) |
RNA binding | TAR DNA-binding protein 43 | Homo sapiens (human) |
mRNA 3'-UTR binding | TAR DNA-binding protein 43 | Homo sapiens (human) |
protein binding | TAR DNA-binding protein 43 | Homo sapiens (human) |
lipid binding | TAR DNA-binding protein 43 | Homo sapiens (human) |
identical protein binding | TAR DNA-binding protein 43 | Homo sapiens (human) |
pre-mRNA intronic binding | TAR DNA-binding protein 43 | Homo sapiens (human) |
molecular condensate scaffold activity | TAR DNA-binding protein 43 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
intracellular non-membrane-bounded organelle | TAR DNA-binding protein 43 | Homo sapiens (human) |
nucleus | TAR DNA-binding protein 43 | Homo sapiens (human) |
nucleoplasm | TAR DNA-binding protein 43 | Homo sapiens (human) |
perichromatin fibrils | TAR DNA-binding protein 43 | Homo sapiens (human) |
mitochondrion | TAR DNA-binding protein 43 | Homo sapiens (human) |
cytoplasmic stress granule | TAR DNA-binding protein 43 | Homo sapiens (human) |
nuclear speck | TAR DNA-binding protein 43 | Homo sapiens (human) |
interchromatin granule | TAR DNA-binding protein 43 | Homo sapiens (human) |
nucleoplasm | TAR DNA-binding protein 43 | Homo sapiens (human) |
chromatin | TAR DNA-binding protein 43 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | |||
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (29.39) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |